Back to Trials
NCT07388355NARecruitingAccepts Healthy Volunteers

A Usability Study of a Multi-channel ECG Monitoring Device

Wearlinq

Start Date

7/6/2026

Completion Date

7/31/2027

Summary

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Detailed Description

Once eligibility is determined, participants will receive and apply the WearLinq patch for 7 consecutive days (or until an endpoint is met). A subset of subjects will be asked to participate in an Extended Use Cohort (30 days).

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Adult \>18 years old and able to consent * Capable of using a smartphone app * Willing to shave patch area if needed Exclusion Criteria: * Planning to undergo an MRI during the study period * Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results * Presence of pacemaker, ICD or other implanted electronic devices * Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum) * Pregnant or intending to become pregnant during the course of the study

Interventions

DEVICE

eWave Patch

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Healthy Adult ParticipantsHeart DiseaseArrythmiaCardiac

Locations

ABio Clinical Research Partners

New London, North Carolina 28127

United States